Bharat Biotech's Covaxin may have some advantages over other vaccines on its effect over the new variant of coronavirus recently discovered in the UK.Dr Balram Bhargava's statement came on the day the Drugs Controller General of India (DCGI) approved the Oxford coronavirus vaccine and Bharat Biotech's Covaxin for immediate use."NIV scientists have successfully isolated the new virus strain and this will be tested against different vaccines.
We hope potentially Bharat Biotech vaccine will have some advantages over other vaccines on this new strain," said Bhargava as the country has detected 29 patients of the new variant."New virus variant which is now more than 60% infective and creating havoc in the UK is worrisome.